nortriptyline has been researched along with Anxiety Disorders in 33 studies
Nortriptyline: A metabolite of AMITRIPTYLINE that is also used as an antidepressive agent. Nortriptyline is used in major depression, dysthymia, and atypical depressions.
nortriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(methylamino)propylidene group at position 5. It is an active metabolite of amitriptyline.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Among 811 adults with moderate-to-severe depression, melancholic, atypical, anxious and anxious-somatizing depression subtypes established at baseline were evaluated as predictors of outcome of treatment with flexible dosage of the SSRI escitalopram or the tricyclic antidepressant nortriptyline." | 2.76 | Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. ( Aitchison, KJ; Dernovsek, MZ; Farmer, A; Hauser, J; Henigsberg, N; Kalember, P; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Souery, D; Uher, R; Zobel, A, 2011) |
| "Paroxetine-treated subjects received a psychotherapy tailored for traumatic grief." | 2.69 | A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief. ( Houck, PR; Jacobs, S; Miller, MD; Prigerson, HG; Reynolds, CF; Shear, MK; Zygmont, M, 1998) |
| "Although anxiety is associated with Parkinson's disease, anxiety disorders can begin before the onset of motor symptoms, and have been linked to a possible abnormality of dopaminergic, serotonergic, and adrenergic neurons that precedes motor disturbance." | 2.58 | Pharmacological interventions for anxiety in Parkinson's disease sufferers. ( Kohsaka, M; Oeda, T; Park, K; Sawada, H; Tomita, S; Umemura, A; Yamamoto, K, 2018) |
| "It is important to understand both the kinetic and the dynamic implications of dosing TCAs and BZs in the elderly, for whom these drugs are frequently prescribed." | 2.37 | Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics. ( Cutler, NR; Narang, PK, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (51.52) | 18.7374 |
| 1990's | 9 (27.27) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawada, H | 1 |
| Umemura, A | 1 |
| Kohsaka, M | 1 |
| Tomita, S | 1 |
| Park, K | 1 |
| Oeda, T | 1 |
| Yamamoto, K | 1 |
| Uher, R | 1 |
| Dernovsek, MZ | 1 |
| Mors, O | 1 |
| Hauser, J | 1 |
| Souery, D | 1 |
| Zobel, A | 1 |
| Maier, W | 1 |
| Henigsberg, N | 1 |
| Kalember, P | 1 |
| Rietschel, M | 1 |
| Placentino, A | 1 |
| Mendlewicz, J | 1 |
| Aitchison, KJ | 1 |
| McGuffin, P | 1 |
| Farmer, A | 1 |
| HUGHES, FW | 1 |
| FORNEY, RB | 1 |
| SEID, B | 1 |
| REEVES, JE | 1 |
| KLINE, NS | 1 |
| SCHACTER, F | 1 |
| LANG, HB | 1 |
| Lenze, EJ | 1 |
| Mulsant, BH | 3 |
| Dew, MA | 1 |
| Shear, MK | 4 |
| Houck, P | 1 |
| Pollock, BG | 1 |
| Reynolds, CF | 4 |
| Kurpius, MP | 1 |
| Alexander, B | 1 |
| Dombrovski, AY | 1 |
| Blakesley-Ball, RE | 1 |
| Mazumdar, S | 2 |
| Houck, PR | 4 |
| Szanto, K | 2 |
| Wiesegger, G | 1 |
| Kienbacher, C | 1 |
| Pellegrini, E | 1 |
| Scheidinger, H | 1 |
| Vesely, C | 1 |
| Bangerl, W | 1 |
| Friedrich, M | 1 |
| Cutler, NR | 1 |
| Narang, PK | 1 |
| Valle-Jones, JC | 3 |
| Craven, JR | 1 |
| Wallis, TD | 1 |
| Schiff, AA | 4 |
| Hyde, C | 1 |
| Goldberg, D | 1 |
| Davidson, J | 1 |
| Linnoila, M | 1 |
| Raft, D | 1 |
| Turnbull, CD | 1 |
| Powell, BJ | 1 |
| Campbell, JL | 1 |
| Landon, JF | 1 |
| Liskow, BI | 1 |
| Thomas, HM | 1 |
| Nickel, EJ | 1 |
| Dale, TM | 1 |
| Penick, EC | 1 |
| Samuelson, SD | 1 |
| Lacoursiere, RB | 1 |
| Brown, C | 2 |
| Schulberg, HC | 2 |
| Madonia, MJ | 1 |
| Flint, AJ | 1 |
| Rifat, SL | 1 |
| Wamboldt, MZ | 1 |
| Yancey, AG | 1 |
| Roesler, TA | 1 |
| Zygmont, M | 1 |
| Prigerson, HG | 1 |
| Miller, MD | 2 |
| Jacobs, S | 1 |
| Lecrubier, Y | 1 |
| Swartz, CM | 1 |
| Guadagno, G | 1 |
| Walsh, MR | 2 |
| Dunckley, HG | 1 |
| Sinclair, JM | 2 |
| Pacini, L | 1 |
| Filippini, G | 1 |
| Brodie, NH | 1 |
| McGhie, RL | 1 |
| O'Hara, H | 1 |
| O'Hara, J | 1 |
| Rodway, AE | 1 |
| Maisto, F | 1 |
| Stein, MB | 1 |
| Uhde, TW | 1 |
| Frances, A | 1 |
| Flaherty, JA | 1 |
| Sallent Herranz, JA | 1 |
| Sep-Kowalik, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00005461] | 0 participants | Observational | 1991-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for nortriptyline and Anxiety Disorders
| Article | Year |
|---|---|
Pharmacological interventions for anxiety in Parkinson's disease sufferers.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Dopamine; Dopamine Agonists; Humans; Nortriptyl | 2018 |
[Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
Topics: Adrenergic Uptake Inhibitors; Antipsychotic Agents; Anxiety Disorders; Atomoxetine Hydrochloride; At | 2007 |
Implications of dosing tricyclic antidepressants and benzodiazepines in geriatrics.
Topics: Adipose Tissue; Adult; Aged; Aging; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorde | 1984 |
Cardiovascular effects of tricyclic antidepressants in childhood asthma: a case series and review.
Topics: Adolescent; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Anxiety Disorders; Asthma; B | 1997 |
The impact of comorbidity on the treatment of panic disorder.
Topics: Agoraphobia; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Mental Disorders; Nortript | 1998 |
14 trials available for nortriptyline and Anxiety Disorders
| Article | Year |
|---|---|
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders | 2011 |
Good treatment outcomes in late-life depression with comorbid anxiety.
Topics: Age of Onset; Aged; Aged, 80 and over; Aging; Antidepressive Agents, Second-Generation; Antidepressi | 2003 |
Mixed anxiety/depressive illness in general practice. A therapeutic comparison of nomifensine with fluphenazine/nortriptyline.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depressive Disorder; Double-Blind Method; Drug Combinati | 1983 |
A double-blind, placebo-controlled study of nortriptyline and bromocriptine in male alcoholics subtyped by comorbid psychiatric disorders.
Topics: Adult; Alcoholism; Antisocial Personality Disorder; Anxiety Disorders; Bromocriptine; Comorbidity; D | 1995 |
Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders.
Topics: Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Comorbidity; | 1996 |
Anxious depression in elderly patients. Response to antidepressant treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Combined Modality Therapy; Depres | 1997 |
Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Comorbidity; Depressiv | 1996 |
A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief.
Topics: Adjustment Disorders; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive D | 1998 |
Melancholia with onset during treatment with SSRIs.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Dis | 1998 |
A test of the concept of "underlying depressive illness" in the treatment of anxiety states.
Topics: Adjustment Disorders; Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Drug | 1976 |
[Clinical study with a combination of fluphenazine and nortriptyline in 70 cases of anxiety-depressive neuroses].
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Anxiety Disorders; Clinical Trials as Topic; Drug Com | 1977 |
Once daily administration of a fluphenazine/nortriptyline preparation in the treatment of mixed anxiety/depressive states.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Anxiety Disorders; Clinical Trials as Topic; Drug Adm | 1976 |
Treatment of anxiety/depressive conditions in the elderly: a double-blind comparative study of Motival and amitriptyline.
Topics: Aged; Amitriptyline; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Double-Blind | 1975 |
Triiodothyronine potentiation of tricyclic antidepressant treatment in patients with panic disorder.
Topics: Adult; Anxiety Disorders; Arousal; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipra | 1990 |
14 other studies available for nortriptyline and Anxiety Disorders
| Article | Year |
|---|---|
Delayed audiofeedback (DAF) for induction of anxiety. Effect of nortriptyline, ethanol, or nortriptyline-ethanol combinations on performance with DAF.
Topics: Anxiety; Anxiety Disorders; Ethanol; Humans; Mental Processes; Motor Skills; Nortriptyline | 1963 |
A STUDY OF THE ANTIANXIETY EFFECT OF NORTRIPTYLINE IN UROLOGICAL PATIENTS.
Topics: Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Biomedical Re | 1964 |
NORTRIPTYLINE: A NEW ANTIDEPRESSANT EVALUATED IN A GENERAL MEDICAL PRACTICE.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Anxiety Disorders; Biomedical Research; Geriatrics; N | 1964 |
NORTRIPTYLINE IN PRIVATE PRACTICE.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Drug Therapy; No | 1965 |
CLINICAL REPORT ON PARENTERAL NORTRIPTYLINE.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bipolar Disorder; Depression; Depressive Disorder | 1965 |
Rates of in vivo methylation of desipramine and nortriptyline.
Topics: Aged, 80 and over; Antidepressive Agents, Tricyclic; Anxiety Disorders; Depressive Disorder; Desipra | 2006 |
Speed of improvement in sleep disturbance and anxiety compared with core mood symptoms during acute treatment of depression in old age.
Topics: Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Cognitive Behavioral Therapy; Combined Mo | 2006 |
Labelling and drug effects in the treatment of neurotic affective disorders: an experimental investigation.
Topics: Adolescent; Adult; Aged; Anxiety Disorders; Depressive Disorder; Diazepam; Double-Blind Method; Fema | 1983 |
MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study.
Topics: Adult; Amitriptyline; Anxiety Disorders; Blood Platelets; Female; Humans; Male; Monoamine Oxidase; M | 1981 |
Treatment outcome in suicidal vs. non-suicidal elderly patients.
Topics: Aged; Antidepressive Agents; Anxiety Disorders; Depressive Disorder, Major; Female; Humans; Male; No | 2001 |
[The anxious-depressive syndrome. Polycentric study with the collaboration of 1,048 Italian physicians].
Topics: Adjustment Disorders; Adult; Aged; Anxiety Disorders; Female; Fluphenazine; Humans; Male; Middle Age | 1977 |
Elderly widow develops panic attacks, followed by depression.
Topics: Aged; Anxiety Disorders; Depressive Disorder; Fear; Female; Humans; Nortriptyline; Panic; Psychother | 1989 |
[Gastrointestinal diseases associated with emotional processes. Personal clinical experience].
Topics: Adjustment Disorders; Adult; Aged; Anxiety Disorders; Female; Gastrointestinal Diseases; Humans; Mal | 1968 |
[Effects of dibenzocycloheptadienic derivatives in treatment of depressive syndromes].
Topics: Amitriptyline; Anxiety Disorders; Depression; Humans; Nortriptyline; Schizophrenia | 1966 |